Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Loews Royal Pacific Resort at Universal Orlando Resort

Mar 21, 2022 7:00 AM - Mar 23, 2022 5:00 PM

6300 Hollywood Way, Orlando, FL 32819

Medical Affairs and Scientific Communications Forum

DIA Your Way! Join us live in-person or live from the comfort of your home/office. This event offers two learning avenues depending on your preference!

Session 8 Track 2: Transparency and Public Disclosure Requirements for Medical Writing Submission Documents

Session Chair(s)

Ruggero  Galici, PhD

Ruggero Galici, PhD

Director, Nonclinical and Clinical Pharmacology Writing

Alexion Pharmaceuticals, AstraZeneca Rare Disease, United States

The EU is launching two electronic systems that will facilitate clinical data transparency and public disclosure. The Clinical Trial Information System (CTIS) and the European Database for Medical Devices (Eudamed) are expected to be functional in 2022. This presentation will discuss the changes in transparency and disclosure requirements in the EU, and the global impact of these new requirements on global submission documents. Early experiences with these systems will be shared, including the documents impacted, how they are impacted, and the timelines involved.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Describe the new requirements in transparency and public disclosure in the EU in connection with the new systems CTIS and Eudamed
  • Identify the medical writing documents impacted and how they are impacted
  • Describe the role that medical writers in complying with the requirements of CTIS and Eudamed


Raquel  Billiones, DrSc


Raquel Billiones, DrSc

Alexion Pharmaceuticals (AstraZeneca Rare Disease), Switzerland

Director, Medical Writing

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.